TickerFacts.

Dare Bioscience, Inc. (DARE): Revenue

Annual figures by period end, from SEC filings.

$1.03M
Year ended 2025-12-31
$1.37M
Trailing 12 months to 2026-06-30
-53.1%
3-year compound annual growth
$10.00M2012-12-31: $625.0K2013-12-31: $6.0K2014-12-31: $80.0K2016-12-31: $766.0K2021-12-31: $02022-12-31: $10.00M2023-12-31: $2.81M2024-12-31: $9.8K2025-12-31: $1.03M$1.03M
2012-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$1.03Mn/m2026-03-26, From 2025-01-01
2024-12-31$9.8K-99.7%2026-03-26, From 2024-01-01
2023-12-31$2.81M-71.9%2025-03-31, From 2023-01-01
2022-12-31$10.00Mn/a2023-03-30, From 2022-01-01
2021-12-31$0n/a2023-03-30, From 2021-01-01
No annual figure between 2016-12-31 and 2021-12-31.
2016-12-31$766.0Kn/a2017-06-13, From 2016-01-01
No annual figure between 2014-12-31 and 2016-12-31.
2014-12-31$80.0Kn/m2017-06-13, From 2014-01-01
2013-12-31$6.0K-99.0%2016-03-10, From 2013-01-01
2012-12-31$625.0Kn/a2015-03-19, From 2012-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Dare Bioscience, Inc. (DARE)2025-12-31$1.03Mn/m
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$1.01M+65.5%
Shattuck Labs, Inc. (STTK)2025-12-31$1.00M-82.5%
Bespoke Extracts, Inc. (BSPK)2024-12-31$1.12M+42.3%
China SXT Pharmaceuticals, Inc. (SXTC)2026-03-31$1.14M-34.6%
Rafael Holdings, Inc. (RFL)2025-07-31$917.0K+44.0%
Neuphoria Therapeutics Inc. (NEUP)2026-06-30$1.17M-92.5%
Longeveron Inc. (LGVN)2025-12-31$1.20M-49.9%
Rallybio Corp (RLYB)2025-12-31$858.0K+34.9%

Compare DARE, SXTP, STTK, BSPK side by side · Screen every company in Pharmaceutical Preparations ↗